The Phentolamine Test in Neurogenic Bladder Dysfunction
- 31 March 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 117 (4) , 481-485
- https://doi.org/10.1016/s0022-5347(17)58503-1
Abstract
In an attempt to improve the selection of patients with neurogenic bladder dysfunction likely to benefit from phenoxybenzamine therapy, the effect of i.v. phentolamine (Regitine) on the urinary flow rate was determined in normal and abnormal subjects. A nomogram relating mean flow rate to volume voided was constructed to aid in the interpretation of results. In 16 patients with neurogenic bladder dysfunction, a response of more than 0.8 nomogram units indicated a likelihood of clinical improvement with phenoxybenzamine therapy. The clinical applications of this test are discussed.This publication has 31 references indexed in Scilit:
- Some Clinical Implications of Adrenergic Receptors in the Urinary TractArchives of Surgery, 1975
- Treatment with Phenoxybenzamine of Upper Urinary Tract Complications Caused by Intravesical ObstructionJournal of Urology, 1975
- Periurethral Striated Muscle Activity in Neurogenic Bladder DysfunctionJournal of Urology, 1974
- THE NEUROPATHIC URETHRAThe Lancet, 1974
- Phenoxybenzamine in Neurogenic Bladder Dysfunction. I. A Theory of MicturitionJournal of Urology, 1973
- Phenoxybenzamine in Neurogenic Bladder Dysfunction. II. Clinical ConsiderationsJournal of Urology, 1973
- Cystometric and sphincter abnormalities in multiple sclerosisNeurology, 1973
- Critical Evaluation of Uroflowmeters and Analysis of Normal CurvesJournal of Urology, 1973
- The Physiology of the Internal Urinary SphincterJournal of Urology, 1970
- A CONTRIBUTION TO THE NEUROPHYSIOLOGY OF THE URINARY BLADDER IN MANBrain, 1931